3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…
Tagged with Global
Enough COVID Vaccines for World Population Says IFPMA: Calls for…
Pharma industry leaders have called for rich nations to stop stockpiling excess COVID-19 vaccine doses and stated that there will be enough production…
Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare…
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the…
Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for…
Note to Biogen: Your Marketing is Showing
In his latest PharmaBoardroom piece, John Singer looks at Biogen’s marketing campaign for its new Alzheimer’s drug, extending and linking the…
PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So Far)
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!), from well covered markets such as Singapore and Switzerland to new…
PharmaBoardroom’s Top 5 Op-Eds in 2021 (So Far)
As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are happy to share the five most-read articles from our global…
Inserting the Patient Voice: Ethical Challenges in the Use of…
Patient advocate and regular PharmaBoardroom contributor Monica Weldon examines how healthcare’s data revolution has thus far largely ignored the…
João de Bragança & Nicole Scobie, Childhood Cancer…
Cancer is one of the most frightening words in any language but is especially heart-wrenching when it comes to children. João de Bragança, President…
Aducanumab Approval: Opening the Floodgates for a New Era of…
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval for a new Alzheimer’s disease…
Five Ways That AI Can Transform Pharma Market Access
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland outlines how AI has already begun to transform pharmaceutical…
Industry Warns of Vaccine Manufacturing Bottlenecks; Specific…
Big Pharma’s representatives are warning of upcoming bottlenecks in the COVID-19 vaccine manufacturing supply chain and are asking for a unified…
